ARS Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $11.9M | $394.8M | $386.6M |
| FY2021 | $16.7M | $61.4M | $60.1M |
| FY2022 | $8.5M | $281.4M | $210.5M |
| FY2023 | $2.4M | $233.2M | $71.0M |
| FY2024 | $94.4M | $351.2M | $50.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $11.9M | $394.8M | $386.6M |
| FY2021 | $16.7M | $61.4M | $60.1M |
| FY2022 | $8.5M | $281.4M | $210.5M |
| FY2023 | $2.4M | $233.2M | $71.0M |
| FY2024 | $94.4M | $351.2M | $50.8M |